Disseminated Intravascular Coagulation in the Emergency Department: High-Yield MRCEM SBA Revision Notes

Disseminated intravascular coagulation (DIC) sits at the intersection of haematology, critical care and emergency medicine — a condition that rarely presents in isolation, almost always heralds serious underlying pathology, and carries a mortality that demands rapid, structured thinking. For trainees working through MRCEM SBA revision notes, DIC is a reliable exam topic precisely because it tests several competencies at once: pathophysiological reasoning, investigation interpretation, blood product decision-making, and appropriate escalation. The Royal College of Emergency Medicine curriculum places coagulopathy firmly within the haematological and critical care domains, and DIC-based clinical scenarios appear with regularity in MRCEM SBA exam questions.

Definition, Epidemiology and Clinical Context

DIC is an acquired syndrome characterised by systemic activation of coagulation that is both excessive and dysregulated. Clotting factors and platelets are consumed faster than they can be replenished, producing a paradoxical state in which widespread microvascular thrombosis occurs alongside systemic haemorrhagic diathesis. The International Society on Thrombosis and Haemostasis (ISTH) defines DIC as an acquired syndrome characterised by the intravascular activation of coagulation with loss of localisation arising from different causes, able to originate damage to the microvasculature, which, if sufficiently severe, can produce organ dysfunction.

Incidence varies substantially by case mix. In intensive care settings, sepsis-associated DIC affects an estimated 30–50% of patients with severe sepsis or septic shock. In the ED, the conditions most likely to trigger DIC are gram-negative bacteraemia and meningococcaemia, major trauma with traumatic brain injury, obstetric emergencies (placental abruption, amniotic fluid embolism, HELLP syndrome), acute promyelocytic leukaemia, and acute liver failure. Snake envenomation, though uncommon in the UK, appears in MRCEM SBA exam questions as a cause of venom-induced consumption coagulopathy and should not be overlooked. Mortality in septic shock-associated DIC exceeds 40%, underscoring why rapid recognition in the ED directly influences outcome.

Clinically, DIC presents along a spectrum. Overt DIC typically manifests with diffuse bleeding — oozing from venepuncture sites, mucosal haemorrhage, ecchymoses, and in severe cases gastrointestinal or intracranial bleeding — alongside signs of microvascular thrombosis such as peripheral ischaemia, renal impairment and neurological deterioration. Non-overt (compensated) DIC may be clinically silent, detectable only through laboratory indices, and often represents the earliest stage of a deteriorating trajectory. Recognising both presentations is a core MRCEM SBA revision competency.

Pathophysiology: The Mechanism Behind the Coagulopathy

Understanding DIC pathophysiology is not merely academic — it explains why laboratory values change in a predictable sequence, why certain treatments work and others do not, and why the underlying trigger must be controlled before haemostasis can be restored.

Initiation via Tissue Factor

The primary driver of DIC is widespread tissue factor (TF) expression on endothelial cells and monocytes in response to the systemic insult. Endotoxin in gram-negative sepsis, tumour cell procoagulants in malignancy, and placental thromboplastin released in obstetric emergencies all trigger this upregulation. TF binds activated factor VII (FVIIa) to form the extrinsic tenase complex, generating thrombin in quantities that overwhelm physiological inhibitory mechanisms including antithrombin III, protein C and tissue factor pathway inhibitor (TFPI).

Thrombin Excess and Factor Consumption

Excessive thrombin cleaves fibrinogen to fibrin, activates platelets, and simultaneously activates factors V, VIII, XI and XIII — producing a rapidly self-amplifying coagulation cascade. Fibrin clots deposit in the microvasculature, causing end-organ ischaemia. Concurrent plasmin activation (reactive fibrinolysis) degrades fibrin clots, generating D-dimers and fibrin degradation products (FDPs). As fibrinogen, platelets and clotting factors are consumed, the coagulation system becomes progressively depleted, tipping the balance towards haemorrhage. In some conditions — notably APL and amniotic fluid embolism — hyperfibrinolysis dominates, producing a predominantly haemorrhagic phenotype from the outset.

Microangiopathic Haemolytic Anaemia

Red cells are physically sheared as they pass through fibrin-obstructed microvasculature, producing schistocytes on the blood film — a morphological finding that, in the correct clinical context, adds diagnostic weight to the laboratory picture of DIC. The BMJ has published extensively on the distinction between DIC and thrombotic microangiopathies (TTP, HUS), which share some laboratory features but require fundamentally different treatment pathways — a distinction the exam frequently tests.

ED Assessment and Management

History and Examination

The history should focus on identifying the precipitating cause: fever and rigors suggesting sepsis, mechanism of injury in trauma, obstetric history, known malignancy, and medication history (including anticoagulants that may confound the coagulation profile). Examination should assess haemodynamic stability, signs of end-organ dysfunction (altered consciousness, oliguria, mottled peripheries), and evidence of both bleeding (petechiae, ecchymoses, active haemorrhage) and thrombosis (digital ischaemia, purpura fulminans).

Investigations

The core investigation panel for suspected DIC in the ED comprises: full blood count (thrombocytopenia, anaemia), coagulation screen (prolonged PT and APTT), fibrinogen level, D-dimer, blood film (schistocytes), renal and liver function tests, and cultures plus lactate if sepsis is suspected. Point-of-care viscoelastic testing (ROTEM or TEG) is increasingly available in major trauma centres and provides real-time functional coagulation data that guides targeted blood product replacement — knowledge of these tools is relevant for FRCEM SBA critical care revision.

The ISTH overt DIC scoring system provides a validated, reproducible diagnostic framework:

• Platelet count: greater than 100 x10⁹/L = 0; 50–100 = 1; less than 50 = 2
• PT prolongation: less than 3 seconds = 0; 3–6 seconds = 1; greater than 6 seconds = 2
• Fibrinogen: greater than 1 g/L = 0; less than 1 g/L = 1
• D-dimer / fibrin-related markers: no increase = 0; moderate increase = 2; strong increase = 3

A score of 5 or more is compatible with overt DIC and should prompt immediate treatment. A score of 4 or less suggests non-overt DIC; repeat testing every 1–2 hours is appropriate in an evolving clinical picture. Fibrinogen alone deserves emphasis: in obstetric DIC, a falling fibrinogen level below 2 g/L is strongly predictive of severe postpartum haemorrhage, as highlighted by NICE guidance on intrapartum care.

Management Principles

1. Treat the underlying cause. This is the single most important intervention. Without addressing sepsis (antibiotics, source control), delivering the placenta, or initiating ATRA in APL, haemostatic support is a temporising measure at best.

2. Correct haemostatic deficits in active haemorrhage. Fresh frozen plasma (FFP) at 15 ml/kg replaces multiple clotting factors and is indicated when PT and APTT are greater than 1.5 times normal with active bleeding. Cryoprecipitate (containing concentrated fibrinogen, factor VIII, vWF and factor XIII) is indicated when fibrinogen falls below 1.5 g/L in the context of bleeding — 2 pools (10 units) typically raise adult fibrinogen by approximately 1 g/L. Platelet transfusion is indicated to maintain platelets above 50 x10⁹/L in actively bleeding patients, or above 20 x10⁹/L prophylactically. Tranexamic acid, an antifibrinolytic, has a role in trauma-associated DIC: the CRASH-2 trial demonstrated mortality benefit when administered within 3 hours of injury, evidence now embedded in Resuscitation Council UK major haemorrhage guidance.

3. Heparin — a nuanced and frequently examined point. Low-dose heparin has a theoretical role in predominantly thrombotic DIC (e.g. purpura fulminans, APL-associated thromboembolism) but should only be initiated on haematology advice and is contraindicated in active haemorrhage. Candidates who reflexively administer heparin to any patient with DIC will lose marks.

4. Escalation and disposition. Patients with confirmed DIC require early haematology input, and in most cases critical care review. Obstetric DIC mandates immediate obstetric and anaesthetic involvement. APL requires same-day commencement of ATRA regardless of the hour — a point that appears in MRCEM SBA clinical scenarios testing prioritisation and escalation.

How the MRCEM SBA Exam Tests This Topic

DIC questions in the MRCEM SBA exam characteristically present a clinical vignette — a deteriorating septic patient with worsening haemorrhage, a postpartum woman with uncontrolled bleeding, or a trauma patient with coagulopathy — followed by a laboratory panel and a question requiring either diagnosis (applying the ISTH score), investigation interpretation, or selection of the most appropriate immediate management step.

The RCEM curriculum maps DIC to the haematological emergencies domain, with cross-reference to sepsis, major trauma and obstetric emergencies. The exam tests the following with particular frequency: (1) recognition of overt versus non-overt DIC using the ISTH score; (2) correct identification of the precipitating cause from clinical context; (3) selection of the appropriate blood product for a specific laboratory deficit; (4) understanding that treating the cause takes precedence over all haemostatic interventions; and (5) identifying APL as a haematological emergency requiring urgent ATRA. Candidates preparing with MRCEM SBA practice questions should ensure they can calculate the ISTH score from a given set of results and map the score to a management decision within seconds — this is a timed paper.

If you are looking for structured, exam-mapped question banks and clinical scenario practice, the MRCEM Single Best Answer revision course at EM Learning Centre provides detailed worked explanations for exactly these high-stakes haematology and critical care vignettes.

Revision Pearls: High-Yield Facts for MRCEM SBA

1. DIC is always secondary — the underlying cause drives prognosis and must be treated simultaneously with haemostatic support.
2. ISTH overt DIC score of 5 or more confirms the diagnosis; the score uses platelet count, PT prolongation, fibrinogen and D-dimer.
3. Fibrinogen is consumed early in DIC and its fall below 2 g/L in obstetric patients signals severe haemorrhage risk; cryoprecipitate is the preferred replacement product.
4. APL produces the most severe DIC encountered in haematological malignancy; ATRA must be started as a matter of urgency — do not wait for bone marrow confirmation.
5. Schistocytes on blood film reflect microangiopathic haemolysis; their presence alongside thrombocytopenia and coagulopathy supports DIC but must be distinguished from TTP and HUS, which require different management.
6. Tranexamic acid within 3 hours of major trauma reduces mortality — its mechanism (antifibrinolysis) directly counters the hyperfibrinolytic component of trauma-associated DIC.
7. Heparin is not a first-line treatment for DIC in the ED — its use is restricted to specific thrombotic phenotypes and must always involve haematology.
8. Repeat the ISTH score every 1–2 hours in evolving presentations; dynamic changes in laboratory indices carry as much diagnostic weight as the initial values.

Common Pitfalls: Where Candidates Lose Marks

• Selecting heparin as first-line management in a haemorrhagic DIC scenario — this is almost universally incorrect in the ED context.
• Failing to identify APL as the precipitant when a young patient presents with pancytopenia, severe coagulopathy and blast cells on film — the answer is urgent haematology referral and ATRA, not simply blood products.
• Treating the coagulopathy in isolation without addressing the trigger — questions testing management hierarchy will mark this down.
• Confusing DIC with TTP: TTP lacks significant PT/APTT prolongation and does not respond to FFP in the way DIC does; plasma exchange is the treatment for TTP.
• Using FFP when fibrinogen replacement is specifically required — cryoprecipitate delivers far higher fibrinogen per unit volume and is the correct product choice.
• Overlooking the obstetric context — placental abruption and amniotic fluid embolism are high-frequency exam triggers; not involving obstetrics immediately is a disposition error.

How EM Learning Centre Supports Your MRCEM Single Best Answer Revision

Preparing for the MRCEM SBA exam requires more than passive reading — it demands repeated exposure to high-quality, exam-mapped clinical scenarios with detailed, evidence-based explanations. At the EM Learning Centre homepage, our MRCEM Single Best Answer course is built around exactly the kind of complex, multi-system cases that the exam uses to differentiate candidates: conditions like DIC, where pathophysiology, investigation interpretation and management hierarchy converge in a single question stem. Our worked question bank covers haematological emergencies, critical care, major trauma, toxicology and the full breadth of the MRCEM SBA syllabus, with explanations written at the level of peer-reviewed clinical education. Whether you are building your knowledge base from scratch or refining your exam technique in the final weeks before your sitting, structured MRCEM SBA online revision through EM Learning Centre provides the depth and clinical rigour that this exam demands.

References

1. Royal College of Emergency Medicine. RCEM Curriculum and Competency Framework. rcem.ac.uk
2. National Institute for Health and Care Excellence. Intrapartum Care and Major Obstetric Haemorrhage Guidance. nice.org.uk
3. Resuscitation Council UK. Major Haemorrhage and Traumatic Coagulopathy Guidelines. resus.org.uk
4. The BMJ. Clinical Review: Disseminated Intravascular Coagulation. bmj.com
5. RCEM Learning. Haematological Emergencies in the Emergency Department. rcemlearning.co.uk